New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinking skills were revealed by multiple studies reported today at the Alzheimer’s Association International Conference® (AAIC®) 2022 in San Diego and virtually.
Among the key findings reported at AAIC 2022:
- A group from Argentina found that persistent loss of the sense of smell may be a better predictor of long-term cognitive and functional impairment than severity of the initial COVID-19 disease.
- Hospitalization in the intensive care unit was associated with double the risk of dementia in older adults, according to a study by Rush Alzheimer's Disease Center in Chicago.
- During the pandemic, female gender, not working and lower socioeconomic status were associated with more cognitive symptoms in a large study population drawn from nine Latin American countries.
- In that same Latin American population, experiencing a positive life change during the pandemic (such as more quality time with friends and family or spending more time in nature) reduced the negative impact of the pandemic on memory and thinking skills.
“COVID-19 has sickened and killed millions of people around the world, and for some, the emerging research suggests there are long-term impacts on memory and thinking as well,” said Heather M. Snyder, Ph.D., vice president of medical and scientific relations at the Alzheimer’s Association. “As this virus will likely be with us for a long time, identifying the risk and protective factors for cognitive symptoms can assist with the treatment and prevention of ‘long COVID’ moving forward.”
Persistent loss of smell better predicts cognitive impairment than severity of COVID-19
Researchers in Argentina working with the Alzheimer’s Association Consortium on Chronic Neuropsychiatric Sequelae of SARS-CoV-2 Infection followed 766 adults age 55-95 exposed to COVID-19 for one year, and conducted a series of regular physical, cognitive and neuropsychiatric tests. Of the study group, 88.4% were infected and 11.6% were controls.
Clinical assessment showed functional memory impairment in two-thirds of the infected participants, which was severe in half of them. Another group of cognitive tests identified three groups with decreased performance:
- 11.7% showed memory-only impairment.
- 8.3% had impairment in attention and executive function.
- 11.6% displayed multidomain (including memory, learning, attention and executive function) impairment.
Statistical analysis revealed that persistent loss of smell was a significant predictor of cognitive impairment, but severity of the initial COVID-19 disease was not.
The more insight we have into what causes or at least predicts who will experience the significant long-term cognitive impact of COVID-19 infection, the better we can track it and begin to develop methods to prevent it.”
Gabriela Gonzalez-Aleman, LCP, Ph.D., Professor, Pontificia Universidad Catolica Argentina, Buenos Aires
A stay in the intensive care unit may signal higher dementia risk
Researchers from the Rush Alzheimer’s Disease Center (RADC), part of Chicago’s Rush University System for Health, used data from five diverse studies of older adults without known dementia (n=3,822) to observe intensive care unit (ICU) hospitalizations. ICU hospitalizations were previously linked to cognitive impairment in older patients, but few studies have examined whether they increase risk for dementia.
They reviewed Medicare claims records from 1991 to 2018 (pre-pandemic), and checked annually for development of Alzheimer’s and all type dementia using a standardized cognitive assessment. During an average 7.8 years follow up, 1,991 (52%) participants experienced at least one ICU hospitalization; 1,031 (27%) had an ICU stay before study enrollment; and 961 (25%) had an ICU stay during the study period.
The researchers found that, in analyses adjusted for age, sex, education and race, experiencing ICU hospitalization was associated with 63% higher risk of Alzheimer’s dementia and 71% higher risk of all type dementia. In models further adjusted for other health factors such as vascular risk factors and disease, other chronic medical conditions, and functional disabilities, the association was even stronger: ICU hospitalization was associated with 110% greater risk of Alzheimer’s and 120% greater risk of all type dementia.
“We found that ICU hospitalization was associated with double the risk of dementia in community-based older adults,” said Bryan D. James, Ph.D., epidemiologist at RADC. “These findings could be significant given the high rate of ICU hospitalization in older persons, and especially due to the tremendous upsurge in ICU hospitalizations during the COVID-19 pandemic. Understanding the link between ICU hospitalization and the development of dementia is of utmost importance now more than ever.”
“More research is necessary to replicate these findings and elucidate the factors that may increase dementia risk. For example, is it the critical illness that sends someone to the hospital or potentially modifiable procedures during the hospitalization that drives dementia risk?” James added.
One positive life change during the pandemic may buffer against cognitive symptoms
Investigators from countries across Central and South America and the United States examined whether sociodemographic factors and changes in life associated with the pandemic were related to experiencing cognitive symptoms, including problems with memory, attention and other thinking skills, during the early phases of the pandemic.
In the study reported at AAIC, 2,382 Spanish-speaking adults age 55-95 (average 65.3 years, 62.3% female) from nine countries in Latin America completed an online or telephone survey, had electronic cognitive testing, and filled out an inventory assessing the positive and negative impacts of the pandemic between May and December 2020. Of the total study population, 145 (6.09%) experienced COVID-19 symptoms.
Participants were from: Uruguay (1,423, 59.7%), Mexico (311, 13.1%), Peru (153, 6.4%), Chile (152, 6.4%), Dominican Republic (117, 4.9%), Argentina (106, 4.5%), Colombia (50, 2.1%), Ecuador (39, 1.6%), Puerto Rico (19, 0.8%) and Other (12, 0.5%)
Key findings:
- Female gender, not currently working and lower socioeconomic status were all independently associated with more cognitive symptoms during the early part of the pandemic.
- Negative life changes during the pandemic, such as economic difficulties and limited social activities, were significantly associated with more cognitive symptoms. However, this association was weaker among study participants who reported at least one positive life change during the pandemic, including spending more time with friends and family or more time outside in nature.
“Identifying risk and protective factors for cognitive symptoms during the pandemic is an important step towards the development of prevention efforts,” said María Marquine, Ph.D., associate professor in the Departments of Medicine and Psychiatry, and director of disparities research in the Division of Geriatrics, Gerontology and Palliative Care at the University of California, San Diego. “The experience of positive life changes during the pandemic might buffer the detrimental impact of negative life changes on cognitive symptoms.”
“This study is an example of how investigators from diverse countries in Latin America and the United States, many of whom had never worked together before and had limited resources, came together under difficult circumstances but with a shared goal to advance scientific understanding about Alzheimer’s, and the important contributions that such multicultural partnerships can yield,” Marquine added.
Limited impact of prenatal COVID-19 exposure on child neurodevelopmental outcomes